135 related articles for article (PubMed ID: 9385468)
1. Early, short-term treatment with captopril permanently attenuates cardiovascular changes in spontaneously hypertensive rats.
Regan CP; Bishop SP; Berecek KH
Clin Exp Hypertens; 1997 Nov; 19(8):1161-77. PubMed ID: 9385468
[TBL] [Abstract][Full Text] [Related]
2. Effects of aging and antihypertensive treatment on aortic internal diameter in spontaneously hypertensive rats.
Giummelly P; Lartaud-Idjouadiene I; Marque V; Niederhoffer N; Chillon JM; Capdeville-Atkinson C; Atkinson J
Hypertension; 1999 Aug; 34(2):207-11. PubMed ID: 10454442
[TBL] [Abstract][Full Text] [Related]
3. Withdrawal reveals lack of effect of prolonged antihypertensive treatment on intrinsic aortic wall stiffness in senescent spontaneously hypertensive rats.
Marque V; Grima M; Kieffer P; Capdeville-Atkinson C; Atkinson J; Lartaud-Idjouadiene I
Clin Exp Pharmacol Physiol; 2002 Oct; 29(10):898-904. PubMed ID: 12207569
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms responsible for sustained hypotension after captopril treatment.
Chen DG; Jin XQ; Wang HJ; Chen SC
J Hypertens; 1995 Oct; 13(10):1113-21. PubMed ID: 8586803
[TBL] [Abstract][Full Text] [Related]
5. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition.
Guidi E; Hollenberg NK
J Hypertens Suppl; 1986 Dec; 4(6):S480-2. PubMed ID: 11538668
[TBL] [Abstract][Full Text] [Related]
6. Interaction between lifetime captopril treatment and NaCI-sensitive hypertension in spontaneously hypertensive rats and Wistar-Kyoto rats.
Fang Z; Sripairojthikoon W; Calhoun DA; Zhu S; Berecek KH; Wyss JM
J Hypertens; 1999 Jul; 17(7):983-91. PubMed ID: 10419072
[TBL] [Abstract][Full Text] [Related]
7. Captopril improves cerebrovascular structure and function in old hypertensive rats.
Dupuis F; Atkinson J; Limiñana P; Chillon JM
Br J Pharmacol; 2005 Feb; 144(3):349-56. PubMed ID: 15655534
[TBL] [Abstract][Full Text] [Related]
8. Effect of angiotensin-converting enzyme inhibition on myocardial fibrosis and function in hypertrophied and failing myocardium from the spontaneously hypertensive rat.
Brooks WW; Bing OH; Robinson KG; Slawsky MT; Chaletsky DM; Conrad CH
Circulation; 1997 Dec; 96(11):4002-10. PubMed ID: 9403625
[TBL] [Abstract][Full Text] [Related]
9. Effects of salt loading and various therapies on cardiac hypertrophy and fibrosis in young spontaneously hypertensive rats.
Ziegelhöffer-Mihalovicova B; Arnold N; Marx G; Tannapfel A; Zimmer HG; Rassler B
Life Sci; 2006 Jul; 79(9):838-46. PubMed ID: 16624325
[TBL] [Abstract][Full Text] [Related]
10. Captopril avoids hypertension, the increase in plasma angiotensin II but increases angiotensin 1-7 and angiotensin II-induced perfusion pressure in isolated kidney in SHR.
Castro-Moreno P; Pardo JP; Hernández-Muñoz R; López-Guerrero JJ; Del Valle-Mondragón L; Pastelín-Hernández G; Ibarra-Barajas M; Villalobos-Molina R
Auton Autacoid Pharmacol; 2012 Oct; 32(3 Pt 4):61-9. PubMed ID: 22994939
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
De Godoy MA; Rattan S
J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
[TBL] [Abstract][Full Text] [Related]
12. Captopril treatment and its withdrawal prevents impairment of endothelium-dependent responses in the spontaneously hypertensive rat.
Keaton AK; White CR; Berecek KH
Clin Exp Hypertens; 1998 Nov; 20(8):847-66. PubMed ID: 9817606
[TBL] [Abstract][Full Text] [Related]
13. Blood pressure responses to substances interfering with nitric oxide formation, cyclooxygenase and converting enzyme activities and vasopressin V1 receptors blockade in conscious spontaneously hypertensive and normotensive rats.
Januszewicz A; Lapiński M; Styś T; Styś A; Loń S
Pol J Pharmacol; 1994; 46(3):153-61. PubMed ID: 8000447
[TBL] [Abstract][Full Text] [Related]
14. Prevention of arterial structural alterations with verapamil and trandolapril and consequences for mechanical properties in spontaneously hypertensive rats.
Koffi I; Lacolley P; Kirchengaast M; Pomiès JP; Laurent S; Benetos A
Eur J Pharmacol; 1998 Nov; 361(1):51-60. PubMed ID: 9851541
[TBL] [Abstract][Full Text] [Related]
15. Effects of early perturbation of the renin-angiotensin system on cardiovascular remodeling in spontaneously hypertensive rats.
Berecek KH; Reaves P; Raizada M
Vascul Pharmacol; 2005 Feb; 42(3):93-8. PubMed ID: 15792926
[TBL] [Abstract][Full Text] [Related]
16. Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats.
Owens GK
Hypertension; 1987 Feb; 9(2):178-87. PubMed ID: 3546119
[TBL] [Abstract][Full Text] [Related]
17. Prevention of nephrosclerosis and cardiac hypertrophy by captopril treatment of spontaneously hypertensive rats.
Ohashi H; Matsunaga M; Yoshida H; Nagai H; Pak CH; Hara A; Kawai C
Jpn Circ J; 1986 Feb; 50(2):140-6. PubMed ID: 2941600
[TBL] [Abstract][Full Text] [Related]
18. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure.
Christensen KL; Jespersen LT; Mulvany MJ
J Hypertens; 1989 Feb; 7(2):83-90. PubMed ID: 2522478
[TBL] [Abstract][Full Text] [Related]
19. Year-long antihypertensive therapy with candesartan completely prevents development of cardiovascular organ injuries in spontaneously hypertensive rats.
Ishimitsu T; Honda T; Ohno E; Furukata S; Sudo Y; Nakano N; Takahashi T; Ono H; Matsuoka H
Int Heart J; 2010; 51(5):359-64. PubMed ID: 20966610
[TBL] [Abstract][Full Text] [Related]
20. Blockade of angiotensin II provides additional benefits in hypertension- and ageing-related cardiac and vascular dysfunctions beyond its blood pressure-lowering effects.
Demirci B; McKeown PP; Bayraktutan U
J Hypertens; 2005 Dec; 23(12):2219-27. PubMed ID: 16269964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
